11.46MMarket Cap
LossP/E TTM
Key Figures
2.780Open
2.842High
65.40KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
1.51%Turnover Ratio
2.800Prev. Close
2.580Low
120.72KTurnover
LossP/E Static
2.01P/B
0.00%Div Yield TTM
-101.88%ROA
1.14052wk High
1.12Volume Ratio
-6.06MNet Profit
4.34MShares
-1.6248EPS TTM
1.26Beta
-109.58%ROE
0.10052wk Low
9.36%Amplitude
-3381.20%Gross Margin
11.46MMarket Cap
-1.54Reward/Risk
6.83%Risk Rate
Virax Biolabs Group Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Virax Biolabs Group Ltd
VRAX
1
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Virax Biolabs Group Ltd Info
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Ticker SymbolVRAX
CompanyVirax Biolabs Group Ltd
CEOFoster (James)
Websitehttps://www.viraxbiolabs.com
Shareholders
FAQs
What is the current price of Virax Biolabs Group Ltd (VRAX)?
The current price of Virax Biolabs Group Ltd (VRAX) is 2.64.
What is the symbol of Virax Biolabs Group Ltd?
The ticker symbol of Virax Biolabs Group Ltd is VRAX.
What is the 52-week high of Virax Biolabs Group Ltd?
The 52-week high of Virax Biolabs Group Ltd is 1.14.
What is the 52-week low of Virax Biolabs Group Ltd?
The 52-week low of Virax Biolabs Group Ltd is 0.10.
What is the market capitalization of Virax Biolabs Group Ltd?
The market capitalization of Virax Biolabs Group Ltd is 11.46M.
Is Virax Biolabs Group Ltd (VRAX) currently rated as Buy, Hold, or Sell?
According to analysts, Virax Biolabs Group Ltd (VRAX) has an overall rating of Buy, with a price target of 25.00.
What is the Earnings Per Share (EPS TTM) of Virax Biolabs Group Ltd (VRAX)?
The Earnings Per Share (EPS TTM) of Virax Biolabs Group Ltd (VRAX) is -12.64.
